CAMBRIDGE, Mass., Jun 3, 2002 (BUSINESS WIRE) -- Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by UBS Warburg on Wednesday, June 5, 2002 at 9:30am EDT. The presentation will be webcast live from the Grand Hyatt Hotel in New York. To access the audio webcast, go to www.ubswarburg.com. Click on the Conference Highlights link and follow the link for Live Audio under the Global Specialty Pharmaceuticals Conference heading.
Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. We have several areas of focus, including (i) controlled, sustained-release of injectable drugs lasting several days to several weeks, using our ProLease(R) and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on our proprietary AIR(TM) pulmonary technology. In addition to our Cambridge, Massachusetts, headquarters, research and manufacturing facilities, Alkermes operates research and manufacturing facilities in Ohio and a medical affairs office in Cambridge, England.
CONTACT: Alkermes, Inc., Rebecca Peterson, Director, Investor Relations, (617) 583-6378